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Abstract
DNA double-strand breaks (DSBs) represent the most cytotoxic DNA lesions, as—if mis- or unrepaired—they can cause 
cell death or lead to genome instability, which in turn can cause cancer. DSBs are repaired by two major pathways termed 
homologous recombination and non-homologous end-joining (NHEJ). NHEJ is responsible for repairing the vast majority 
of DSBs arising in human cells. Defects in NHEJ factors are also associated with microcephaly, primordial dwarfism and 
immune deficiencies. One of the key proteins important for mediating NHEJ is XRCC4. XRCC4 is a dimer, with the dimer 
interface mediated by an extended coiled-coil. The N-terminal head domain forms a mixed alpha–beta globular structure. 
Numerous factors interact with the C-terminus of the coiled-coil domain, which is also associated with significant self-
association between XRCC4 dimers. A range of construct lengths of human XRCC4 were expressed and purified, and the 
1–164 variant had the best NMR properties, as judged by consistent linewidths, and chemical shift dispersion. In this work 
we report the 1H, 15 N and 13C backbone resonance assignments of human XRCC4 in the solution form of the 1–164 con-
struct. Assignments were obtained by heteronuclear multidimensional NMR spectroscopy. In total, 156 of 161 assignable 
residues of XRCC4 were assigned to resonances in the TROSY spectrum, with an additional 11 resonances assigned to 
His-Tag residues. Prediction of solution secondary structure from a chemical shift analysis using the TALOS + webserver 
is in good agreement with the published X-ray crystal structures of this protein.
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Biological context
Cells are constantly attacked by DNA-damaging agents aris-
ing from exogenous (UV light, ionizing radiation, small 
molecule chemicals in food, drugs and tobacco smoke etc.) 
and endogenous (e.g. reactive oxygen species arising as 
metabolic by-products) sources. Consequently, many thou-
sands of DNA lesions are generated in each cell every day 
(Lieber 2008; Jackson and Bartek 2009). To deal with the 
damage, cells have evolved complex and intricate pathways 
collectively termed the DNA damage response that detect 
the DNA lesions, induce cell cycle checkpoints to allow time 
for their repair, or induce apoptosis or senescence if the 
harm is too severe (Jackson and Bartek 2009; Ciccia and 
Elledge 2010). If left unrepaired, DNA damage can have 
drastic consequences, as demonstrated for example by cer-
tain hereditary DNA repair defects causing cancer predispo-
sition, neurodegenerative disorders, immunodeficiencies 
and/or premature ageing. DNA double-strand breaks (DSBs) 
are particularly cytotoxic as their incorrect repair can give 
rise to chromosomal translocations that can lead to cancer. 
DSBs are predominantly repaired by two pathways: the first 
one, termed homologous recombination (HR), repairs DSBs 
in S/G2 phases of the cell cycle with high fidelity using a 
homologous sequence, usually the sister chromatid, as a tem-
plate. The second one, called non-homologous end-joining 
(NHEJ), can function throughout interphase and is respon-
sible for repairing the majority of DSBs arising in human 
cells, but with less fidelity compared to HR (Jackson and 
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Bartek 2009; Ciccia and Elledge 2010). XRCC4 is one of 
around a handful of NHEJ core factors critical for successful 
end ligations of DSBs (Zhao et al. 2020). NHEJ is initiated 
by the assembly of the DNA-dependent protein kinase 
(DNA-PK) holoenzyme on broken DNA ends. DNA-PK 
comprises DNA-PKcs, the catalytic subunit, and the Ku 
complex, a heterodimer consisting of Ku70 and Ku80￼ 
(Frit et al. 2019). DNA-PK phosphorylates itself and other 
NHEJ factors such as XRCC4 (Normanno et al. 2017), and 
acts as a recruitment platform for NHEJ and NHEJ-associ-
ated factors. XRCC4 is implicated in promoting NHEJ in 
several ways. By binding to XLF, XRCC4 is implicated in 
forming XRCC4-XLF filaments to promote DNA-end syn-
apsis (Jackson and Bartek 2009; Brouwer et al. 2016). More-
over, XRCC4 can bind to the nucleoskeletal protein IFFO1 
to promote accurate ligation of broken DNA ends (Li et al. 
2019). The most established functions of XRCC4 are to bind 
to, stabilize, and enhance the activity of LIG4, the down-
stream DNA ligase required for the final NHEJ step that 
joins the two broken DNA ends together (Lieber 2008; Jack-
son and Bartek 2009). While in-depth knowledge is available 
on the crystal structures of XRCC4 alone and bound to some 
of its interactors￼ , NMR assignments of this DNA repair 
protein are lacking, thereby limiting our ability to study 
lower affinity interactions of XRCC4, not amenable to crys-
tallization, with high resolution.
Human XRCC4 is a 334-amino acid protein (Li et al. 
1995) with a globular N-terminal head domain (amino 
acids 1–115) that folds into a seven-stranded, β-sandwich 
and a helix–turn–helix motif (Junop et al. 2000). Residues 
119–164 comprise a long alpha helical stalk, that forms a 
homodimeric, parallel, coiled-coil interface with recipro-
cal interactions from residues 119–155, with a single left-
handed crossover. Residues 125–165, and 180–210 have 
conventional coiled-coil sequences (as assessed by Deep-
Coil (Ludwiczak et al. 2019)), with residues 165–180 also 
being helical in crystal structures. Biochemical and crystal-
lographic analysis of full-length isolated XRCC4 points to 
the existence of a tetrameric aggregation state in equilibrium 
with a dimeric form of the protein. Sites of protein–pro-
tein interactions have been identified at residues 165–180 
(Sibanda et al. 2001; Wu et al. 2009) and in the N-terminal 
domain at residues 103–106 (Ropars et al. 2011). In addi-
tion, each helical stalk from residues 119 to 135 is in close 
contact with strands 1, 2 and 3 of the head domain that 
belong to the partner subunit, thus rigidifying the connec-
tion between the head domain and the stalk in the XRCC4 
dimer. The dimer interface is predominantly hydrophobic 
and is stabilized and kept in register by one salt bridge and 
two hydrogen bonds. The hydrophobic nature, the extensive-
ness of the interface and the conservation of residues at the 
dimer interface from yeast to human all suggest that this 
crystal dimer persists in solution.
The heterogeneity of the oligomerisation of the alpha 
helical stalks is related to their length. In order to obtain 
well-behaved NMR spectra, a range of constructs was tested, 
namely full-length XRCC4 (1–334), residues 1–138, 1–164, 
1–180 and 1–213. The 1–138 construct represents the mini-
mal length that comprises all the head domain interactions, 
residues 1–164 comprise the minimal coiled-coil structure 
observed in crystal structures, and the 164–180 region 
includes some protein–protein interaction sites. Residues 
180–210 complete the regions with strong coiled-coil pro-
pensity, and the remaining residues are predicted to be dis-
ordered. The optimum solubility and NMR behaviour was 
found for the 1–164 construct (Fig. 1) and in this work we 




A human XRCC4 gene sequence corresponding to residues 
1–164 (with cysteines 93, 128 and 130 mutated to alanines) 
(Wu et al. 2011) was inserted into a pET-28a plasmid vector 
linearised with NcoI/BamHI. This plasmid, together with 
XRCC4 full-length in a pHAT5 plasmid (Wang et al. 2018), 
XRCC4 residues 1–213 in a pET-15b plasmid (Sibanda 
et al. 2001) and XRCC4 residues 1–138 in a pET-28a plas-
mid were generous gifts from Tom Blundell (University 
of Cambridge, UK). For the triple resonance assignment 
spectra, the XRCC4 1–164 plasmid was transformed into 
Escherichia coli BL21-CodonPlus (DE3)-RIL (Stratagene) 
and 2H,15 N,13C-labelled human XRCC4 was expressed in a 
defined isotopically labelled M9 minimal media containing 
99.8%  D2O, 1 g  l−1 15 N-ammonium sulphate and 2 g  l−1 
perdeuterated, 13C glucose. The cells were grown at 37 °C 
with shaking until OD600nm = 0.6 and were induced by 
the addition of 1 mM isopropyl-β-D-thiogalactopyranoside 
(IPTG). After further incubation for 8 h, cells were harvested 
by centrifugation at 4000 rpm for 30 min at 4 °C. The cell 
pellet was resuspended in buffer A (50 mM Tris–HCl pH 
8, 300 mM NaCl, 10% glycerol, 10 mM imidazole, 3 mM 
β-mercaptoethanol) supplemented with cOmplete™ EDTA-
free protease inhibitor cocktail (Roche) (one tablet per 
50 mL of buffer). The cell suspension was lysed on ice by 
sonication for 12 cycles of pulsation for 30 s with 30 s cool-
ing intervals. The cell lysate was then separated by ultra-
centrifugation at 40,000×g (17,000 rpm) for 40 min at 4 °C 
in a Beckman Coulter Avanti JXN-30 centrifuge using a 
JA 30.50 rotor. Cell lysates were filtered using a 0.22 μM 
syringe filter and passed through a HisTrap™ FF column 
(16 × 25 mm, GE HealthCare) equilibrated with 10 column 
volumes of buffer A. Then, the column was washed with 10 
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column volumes of buffer A and eluted in buffer A supple-
mented with 300 mM imidazole. Afterwards, the sample was 
diluted 6 times in buffer B (20 mM Tris–HCl, 5% glycerol, 
10 mM β-mercaptoethanol) and applied to a HiTrap Q HP 
column (GE HealthCare), washed with 10 column volumes 
of buffer B supplemented with 50 mM NaCl and eluted in 
buffer B + 250 mM NaCl. Finally, the XRCC4 solution was 
concentrated to NMR sample concentrations by a VivaSpin 
2 3,000 MWCO centrifugal concentrator and dialysed 
three times against 1 L of buffer C (20 mM HEPES pH 6.8, 
140 mM NaCl, 1 mM EDTA, 2 mM DTT, 100 mM arginine, 
100 mM glutamic acid, 0.02%  NaN3) for 4 h at 4 °C. Pro-
tein concentrations were estimated by absorbance at 280 nm 
 (A280 = 27,960  M−1  cm−1). Several backbone amides had not 
fully exchanged from 2 to 1H by the end of the preparation 
procedures. These amides exchanged passively after 15 days 
at 4 °C, and no further procedure was required to complete 
exchange, and triple resonance experiments were performed 
after this period. All reagents including the stable isotopi-
cally-labelled compounds 15NH4Cl (99%), 13C6,2H7-D-Glu-
cose (U-13C6, 99%; 1,2,3,4,5,6,6-d7 97–98%) and 2H2O 
(99.8%) were purchased with the highest purity from Sigma-
Aldrich and used as received. For the initial NMR suitability 
tests, 15 N 1–138, 1–164, 1–180 and 1–213 XRCC4 plasmids 
were expressed, and the recombinant proteins purified, as 
described above except for 12C-glucose and 1H2O were used 
in the defined isotopically labelled M9 minimal media.
NMR spectroscopy
Protein spectra were recorded at 310 K on a Bruker 800 MHz 
spectrometer with a 1H/13C-15 N TCI cryoprobe equipped 
with z-gradients in 20 mM Hepes pH 6.8, 140 mM NaCl, 
1 mM EDTA, 2 mM DTT, 100 mM arginine, 100 mM glu-
tamic acid, 0.02%  NaN3, unless otherwise specified. XRCC4 
1H-15 N spectra were standard Bruker BEST-TROSY (Favier 
and Brutscher 2011) with phase-sensitive Echo/Antiecho 
gradient selection. NMR samples were supplemented with 
2H2O (10% v/v) and trimethylsilyl propanoic acid (TSP; 
0.5% v/v) for the deuterium lock and as a chemical shift ref-
erence, respectively. Samples were loaded into 5-mm diam-
eter 2H2O-matched Shigemi NMR tubes. 1H chemical shifts 
were referenced to the internal TSP signal, whereas 15 N and 
13C chemical shifts were referenced indirectly using nuclei-
specific gyromagnetic ratios. For the backbone 1H, 15 N and 
13C resonance assignment, standard Bruker 1H-15 N TROSY 
and TROSY-based 3D versions of HNCA (15%), HNCACB 
(15%), HN(CO)CACB (8%), HN(CA)CO (18%) and HNCO 
Fig. 1  1H-15 N TROSY spectrum of the XRCC4 1–138, 1–164, 1–180 and 1–213 dimer complex pH 6.8 and 310 K
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(9%) experiments (Gardner and Kay 1998) were acquired 
using non-uniform sampling with a multidimensional 
Poisson Gap scheduling strategy with sine bell weighting 
(Hyberts et al. 2013), with the percentage of points collected 
indicated in parentheses. A 30 Hz (0.15 ppm) resolution in 
the 13C dimension was obtained after processing (zero-filling 
once). The HNCO spectrum, with one peak per residue in 
the 13C dimension was obtained with 328 hypercomplex 
points, whereas spectra with two peaks per residue (HNCA, 
HN(CO)CACB, HN(CA)CO) were obtained with 656 hyper-
complex points and the HNCACB spectrum with four peaks 
per residue was obtained with 1302 hypercomplex points.
Resonance assignment and data deposition
Backbone 1HN, 15 N, 13Cα, 13Cβ and 13C’ resonances were 
assigned for human XRCC4 dimer using standard triple 
resonance methodology (Gardner and Kay 1998). Spectra 
were processed with TopSpin software version 3.5. Peak 
picking and frequency matching was performed within CCP-
NMR Analysis version 2.5 (Vranken et al. 2005). Additional 
confidence in the assignment was gained by comparison 
between the 1H-15 N TROSY spectra of different constructs, 
with the shorter 1–138 version (see Fig. 1) having equiva-
lent peaks for 136/138 resonances. The backbone 1HN, 15 N 
and 13C chemical shifts have been deposited in the BioMa-
gResBank (http:// www. bmrb. wisc. edu/) under the BMRB 
accession code 50,742. The human XRCC4 construct used 
in this study including the N-terminal His-Tag results in the 
XRCC4 sequence starting with M1-G2-S3-S4-…, but the 
residue numbering is defined as M1-E2-R3-K4…, so the 
N-terminal His-Tag is given negative numbers starting -31, 
which has been used here throughout.
Excluding the 3 proline residues and the N-terminal 
methionine from the 195-residue XRCC4 1–164 protein 
sequence, 167 out of a total of 192 residues were assigned in 
the 1H-15 N TROSY spectrum of the XRCC4 dimer (Fig. 2). 
20 of the unassigned residues are in the His-Tag. Excluding 
the His-Tag, 96% of all backbone resonances were assigned 
(97% of 1HN, 95% of 15 N, 100% of 13Cα, 99% of 13Cβ and 
88% of 13C’ nuclei). There are 5 residues that remain unas-
signed in the 1H-15 N TROSY spectrum (T17, L28, H40, 
L70 and S92, Fig. 2) and their 1H-15 N TROSY correlations 
are likely to be attenuated beyond detection by either fast 
exchange with solvent or intermediate exchange broadening 
on the millisecond timescale (Fig. 3). L28 and L70 colo-
cate in the crystal structures, suggesting that intermediate 
exchange is responsible for the broadening in this area. The 
amides of some residues were resistant to hydrogen–deute-
rium exchange, and remained as 2H in protonated buffer for 
over a week after being prepared in deuterated media. These 
residues were H18-Q22, V33-T37, W43, T44 and E55. The 
residues are all in one β-sheet (formed by strands 2, 3 and 4), 
except for E55 is in the core of helix 2 (Fig. 3). The amides 
exchanged passively after 15 days at 4 °C.
The secondary structure content of XRCC4 was predicted 
by uploading the backbone 1HN, 15 N, 13Cα, 13Cβ and 13C’ 
chemical shifts of the XRCC4 1–164 dimer construct to the 
TALOS + webserver (Shen et al. 2009). Figure 4 illustrates 
the comparison between the predicted secondary structure 
for the solution structure and the secondary structure pre-
sent in the crystal. These data are in very good agreement, 
which indicates that the solution conformation is similar to 
the protein structure observed in the crystal, and provides 
confidence in the assignments of the XRCC4 dimer.
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Fig. 2  1H-15 N TROSY spectrum of the XRCC4 1–164 dimer complex at pH 6.8 and 310 K. The assignments of backbone amide resonances are 
indicated by residue type and sequence number. The lower panel shows the detail of the shaded square in the upper panel
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Supplementary Information The online version contains supplemen-
tary material available at https:// doi. org/ 10. 1007/ s12104- 021- 10035-6.
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Fig. 3  Sequence (a) and structural (b) context of assignment com-
pleteness, and structural context of amide hydrogen protection 
(c). a Coloured bars represent HisTag (blue), N-terminal domain 
(light green), initial helical region (cyan) and conventional coiled-
coil domain (dark green). Sequence is coloured red for unassigned, 
salmon for part assigned (no HN), black for fully assigned residues. 
Additionally, positions of cys-ala mutations are coloured yellow (all 
100% assigned). b is a cartoon representation of the crystal structure 
1ik9, truncated at residue 164, and follows the same colouring as (a). 
c is the same cartoon representation of the crystal structure (pdb entry 
1ik9, Sibanda et al. 2001), but with the hydrogen exchange protected 
amides coloured dark blue
Fig. 4  TALOS + . Comparison 
of TALOS + secondary structure 
prediction (and score, top) with 
the crystal structure (PDB code 
1ik9; bottom), coloured green 
for loops, blue for strand and 
red for helix. Crystal structure 
secondary structure assignment 
by DSSP (Frishman and Argos 
1995). Residue numbering as in 
Fig. 2a and explained in text
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